Enteropathy-associated T-cell lymphoma (patient information)

Jump to navigation Jump to search

Enteropathy-associated T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Enteropathy-associated T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Enteropathy-associated T-cell lymphoma (patient information) On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma (patient information)

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Enteropathy-associated T-cell lymphoma (patient information)

CDC on Enteropathy-associated T-cell lymphoma (patient information)

Enteropathy-associated T-cell lymphoma (patient information) in the news

Blogs on Enteropathy-associated T-cell lymphoma (patient information)

Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma (patient information)

For the WikiDoc page for this topic, click here

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2] Sowminya Arikapudi, M.B,B.S. [3]

Overview

What are the symptoms of Enteropathy-associated T-cell lymphoma?

Some of the symptoms of EATL include:[1]

What causes Enteropathy-associated T-cell lymphoma?

There aren't sufficient studies regarding causes of Enteropathy-associated T-cell lymphoma, in other words, it's not known causes for this disease.

Who is at highest risk?

  • Enteropathy-associated T cell lymphoma type I is more common among those diagnosed with celiac disease, however, type II can be seen in those without celiac disease
  • There is a male gender predilection.

Diagnosis

When to seek urgent medical care?

  • Patients who suffer from malabsorption, unintentional weight loss, diarrhea, fever, night sweat must visit their primary care physicians in order to have an extensive workup done and rule out intestinal lymphoma.

Treatment options

  • Unfortunately tumor is very aggressive in nature and mainstay therapy is supportive. Chemotherapy, surgery or stem cell transplant can be part of treatment depending on the tumor progression and metastasis to adjacent lymph nodes or other internal organs.

Where to find medical care for Enteropathy-associated T-cell lymphoma?

Prevention of Enteropathy-associated T-cell lymphoma

  • There is no prevention methods for enteropathy-associated T cell lymphoma.

What to expect (Outlook/Prognosis)?

  • Prognosis is very poor and the tumor is very aggressive in nature.

Possible complications

Source

Template:WH Template:WS

  1. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (May 2011). "The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications". Blood. 117 (19): 5019–32. doi:10.1182/blood-2011-01-293050. PMC 3109529. PMID 21300984.
  2. Uematsu N, Sumi M, Kaiume H, Takeda W, Kirihara T, Ueki T, Hiroshima Y, Ueno M, Ichikawa N, Watanabe M, Kobayashi H (2018). "[Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy]". Rinsho Ketsueki (in Japanese). 59 (1): 69–74. doi:10.11406/rinketsu.59.69. PMID 29415941.